Literature DB >> 15820262

Comparison of the ovine and porcine animal models for biocompatibility testing of vascular prostheses.

Torsten Ueberrueck1, Joerg Tautenhahn, Lutz Meyer, Olaf Kaufmann, Hans Lippert, Ingo Gastinger, Thorsten Wahlers.   

Abstract

OBJECTIVE: Evaluation of the pig and sheep models for biocompatibility investigations of vascular prostheses (VP).
DESIGN: Comparative analysis of animal experimental investigations involving two different animal models.
MATERIALS AND METHODS: Commercially available polyester vascular prostheses (PET-VP) were implanted into two different animal models (infrarenal porcine aorta and ovine carotid artery). The costs, surgical handling, patency rate, and healing on the basis of macroscopic, microscopic, and immunohistochemical criteria were analyzed over a period of 3 months.
RESULTS: Handling and operating times (63 +/- 10 versus 76 +/- 16 min; P = 0.125) did not differ significantly. The cost of the two animal models was comparable. Integration of the VP was complete in the sheep model, but varied in the pig model (two complete, four incomplete). Complete endothelialization of all VPs was observed in the pig, which contrasted with the sheep with complete (circular) endothelialization only in the region of the anastomosis. The thickness of neointima in the region of the anastomosis differed insignificantly; immunohistochemically, only periprosthetic Ki67 was significantly reduced (28.7 +/- 9.9 versus 6 +/- 0.9%; P = 0.002) in the sheep.
CONCLUSIONS: In the porcine model, extremely good endothelialization of the VP was observed, with formation of a rapid neointimal hyperplasia. The ovine model was characterized by the fact that postoperative follow-up investigations were easy to perform. Complete endothelialization was not observed.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15820262     DOI: 10.1016/j.jss.2004.10.021

Source DB:  PubMed          Journal:  J Surg Res        ISSN: 0022-4804            Impact factor:   2.192


  7 in total

1.  Emergency surgery of the abdominal aorta in a porcine model: two sequential experiments.

Authors:  Francisco S Lozano; José M Rodríguez; Francisco J García-Criado; Jose R Gonzalez-Porras; Fermin M Sanchez-Guijo; Pilar Sanchez-Conde; Jose E García-Sanchez
Journal:  World J Surg       Date:  2008-04       Impact factor: 3.352

2.  Increasing platelet concentration in platelet-rich plasma inhibits anterior cruciate ligament cell function in three-dimensional culture.

Authors:  Ryu Yoshida; Mingyu Cheng; Martha M Murray
Journal:  J Orthop Res       Date:  2013-10-04       Impact factor: 3.494

3.  Education and research using experimental pigs in a medical school.

Authors:  Hozumi Tanaka; Eiji Kobayashi
Journal:  J Artif Organs       Date:  2006       Impact factor: 1.731

4.  Surgical technique for the implantation of tissue engineered vascular grafts and subsequent in vivo monitoring.

Authors:  Maxwell T Koobatian; Carmon Koenigsknecht; Sindhu Row; Stelios Andreadis; Daniel Swartz
Journal:  J Vis Exp       Date:  2015-04-03       Impact factor: 1.355

5.  Use of autologous blood-derived endothelial progenitor cells at point-of-care to protect against implant thrombosis in a large animal model.

Authors:  Alexandra E Jantzen; Whitney O Lane; Shawn M Gage; Ryan M Jamiolkowski; Justin M Haseltine; Lauren J Galinat; Fu-Hsiung Lin; Jeffrey H Lawson; George A Truskey; Hardean E Achneck
Journal:  Biomaterials       Date:  2011-08-15       Impact factor: 12.479

6.  Successful endothelialization and remodeling of a cell-free small-diameter arterial graft in a large animal model.

Authors:  Maxwell T Koobatian; Sindhu Row; Randall J Smith; Carmon Koenigsknecht; Stelios T Andreadis; Daniel D Swartz
Journal:  Biomaterials       Date:  2015-10-14       Impact factor: 12.479

7.  Autologous endothelial progenitor cell-seeding technology and biocompatibility testing for cardiovascular devices in large animal model.

Authors:  Alexandra E Jantzen; Whitney O Lane; Shawn M Gage; Justin M Haseltine; Lauren J Galinat; Ryan M Jamiolkowski; Fu-Hsiung Lin; George A Truskey; Hardean E Achneck
Journal:  J Vis Exp       Date:  2011-09-09       Impact factor: 1.355

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.